E-ISSN 2231-3206 | ISSN 2320-4672
 
2026, Vol: 16, Issue: 1
16 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

Technical Note
Online Published: 22 Oct 2013
 


Difluprednate in ophthalmic practice

Minal M Patel, Deepika Singhal.


Cited By:7

Abstract
The present note deals with the use of drug difluprednate in ophthalmic practice. In last few years, prednisolone acetate and betamethasone are strong steroids in use. Currently, the most widely prescribed strong topical corticosteroids in the US is prednisolone acetate 1%. While it controls inflammation effectively, it has not been shown to consistently address postoperative pain and discomfort in a large clinical trial.3 Chances of side effects like ocular hypertension and cataract formation are higher with these steroids. In june 2008 difluprednate ophthalmic emulsion 0.05% was approved by the US Food and Drug Administration (FDA) for the treatment of inflammation and pain associated with ocular surgery. This was the first ophthalmic steroid approved by the FDA since 1973 as it is high in potency and has good safety profile as well as the ability to reduce postoperative pain.

Key words: Ophthalmic practice, Post Operative, Difluprednate


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Minal M Patel
Articles by Deepika Singhal
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Patel MM, Singhal D. Difluprednate in ophthalmic practice. Natl J Physiol Pharm Pharmacol. 2014; 4(1): 92-94. doi:10.5455/njppp.2014.4.280820132

Web Style

Patel MM, Singhal D. Difluprednate in ophthalmic practice. https://www.njppp.com/?mno=42457 [Access: June 27, 2026]. doi:10.5455/njppp.2014.4.280820132

AMA (American Medical Association) Style

Patel MM, Singhal D. Difluprednate in ophthalmic practice. Natl J Physiol Pharm Pharmacol. 2014; 4(1): 92-94. doi:10.5455/njppp.2014.4.280820132


Vancouver/ICMJE Style

Patel MM, Singhal D. Difluprednate in ophthalmic practice. Natl J Physiol Pharm Pharmacol. (2014), [cited June 27, 2026]; 4(1): 92-94. doi:10.5455/njppp.2014.4.280820132


Harvard Style

Patel, M. M. & Singhal, . D. (2014) Difluprednate in ophthalmic practice. Natl J Physiol Pharm Pharmacol, 4 (1), 92-94. doi:10.5455/njppp.2014.4.280820132


Turabian Style

Patel, Minal M, and Deepika Singhal. 2014. Difluprednate in ophthalmic practice. National Journal of Physiology, Pharmacy and Pharmacology, 4 (1), 92-94. doi:10.5455/njppp.2014.4.280820132


Chicago Style

Patel, Minal M, and Deepika Singhal. "Difluprednate in ophthalmic practice." National Journal of Physiology, Pharmacy and Pharmacology 4 (2014), 92-94. doi:10.5455/njppp.2014.4.280820132


MLA (The Modern Language Association) Style

Patel, Minal M, and Deepika Singhal. "Difluprednate in ophthalmic practice." National Journal of Physiology, Pharmacy and Pharmacology 4.1 (2014), 92-94. Print. doi:10.5455/njppp.2014.4.280820132


APA (American Psychological Association) Style

Patel, M. M. & Singhal, . D. (2014) Difluprednate in ophthalmic practice. National Journal of Physiology, Pharmacy and Pharmacology, 4 (1), 92-94. doi:10.5455/njppp.2014.4.280820132


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

About the JournalThe National Journal of Physiology, Pharmacy and Pharmacology (NJPPP) is a peer-reviewed, open-access journal dedicated to advancing rese ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

Eldaghayes Publisher

www.eldaghayes.com 
 

All correspondence should be addressed to:

National Journal of Physiology, Pharmacy and Pharmacology

Email: info@eldaghayes.com